Visit your local Alkaloid website

Alkaloid AD Skopje, a committed supporter of healthcare and pharmaceuticals in Macedonia, is donating a portion of its innovative liquid Omeprazole production, valued at 12,520,800 MKD, to the PHI University Clinic for Pediatric Diseases and the PHI University Clinic for Respiratory Diseases in Children - Kozle. The donation is intended to facilitate access to essential treatment in this field among the children's population. As per assessments conducted by both healthcare institutions, this donation will provide approximately 200 children with the necessary therapy for one year.

"With this donation aimed at children, a demographic particularly susceptible to certain digestive disorders, our company will help streamline their treatment process and enhance the quality of life for patients. Aligned with our paramount commitment to prioritizing people and health above all, which forms the cornerstone of our mission to promote a healthier life for each individual, Alkaloid has been extending assistance to where it is most needed for decades. The company's dedication to community welfare, particularly focused on its youngest members, remains a core component of its broader corporate responsibility portfolio", noted Alkaloid’s CEO and MB President, Zhivko Mukaetov.

The ready-to-use liquid Omeprazole preparation is primarily designed to treat reflux esophagitis and gastroesophageal reflux disease (GERD) in young children unable to swallow tablets, as well as in adult patients who have difficulty swallowing (dysphagia patients) and those with an inability to swallow (gastric feeding tube patients and/or geriatric patients).

This new product’s novelty lies in enclosing two separate solutions in a dual-chamber package. Upon opening, these solutions automatically mix to provide ready-to-use liquid Omeprazole. The product has a pleasant lemon and menthol flavor and is free from sugar, sorbitol, and artificial coloring.